[ORGANIZATION]
Bixlenvo
Featured in 2 tracked stories · first seen
Situations
Gilead Sciences HIV treatment developments
2 clusters · 4 sources · last updated
Latest: Gilead Sciences receives FDA approval for new once-daily HIV pill
The U.S. Food and Drug Administration (FDA) has approved Gilead Sciences’ Bixlenvo, a once-daily single-pill HIV treatment. The medication combines bictegravir and lenacapavir to assist adult patients who have suppressed